Skip to content
Screener

PTC Therapeutics PTCT Business Segments — Income Tax Expense Benefit

Similar metrics at other companies

Security National Financial Corporation logo
SNFCALife Insurance — Income Tax Expense Benefit
$1.66M-6.8%
U-Haul Holding logo
UHALLife Insurance — Income Tax Expense Benefit
$829K+67.1%
Principal Financial Group logo
PFGSegment Benefits And Protection — Income Tax Expense Benefit
$25.3M+13.7%
United States Lime & Minerals, Inc. logo
USLMLime And Limestone Operations — Income Tax Expense Benefit
$8.43M-5.0%
Cherry Hill Mortgage Investment logo
CHMIRMBS — Income Tax Expense Benefit
$0
Advance Auto Parts logo
AAPReportable — Income Tax Expense Benefit
$11M+107%

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$5.78B+41.9%
Enterprise value$5.34B+54.9%
P/E7.1×
P/S+4.7×

Profitability

See full
Gross margin96%
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:32 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001070081-26-000012
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Interest income$$(17,985)(17,245)
Interest expense67,01551,337
Income tax expense34763,266
Depreciation3,8063,458
Amortization11,5813,798
All other (b)43,12540,809
Total other segment items$$107,889145,423

Item 1. Financial Statements (unaudited)

FAQ

What is PTC Therapeutics's business segments — income tax expense benefit?
PTC Therapeutics (PTCT) reported business segments — income tax expense benefit of $347K in Q1 2026.
How has PTC Therapeutics's business segments — income tax expense benefit changed year-over-year?
PTC Therapeutics's business segments — income tax expense benefit decreased by 99.5% year-over-year, from $63.27M to $347K.
What does business segments — income tax expense benefit mean?
This metric captures the provision for income taxes or the benefit derived from tax credits and adjustments specifically attributed to the Life Science segment's operations. It reflects the fiscal impact of tax jurisdictions on the segment's bottom line. Analyzing this figure assists in understanding the effective tax rate and the impact of tax planning on the segment's net financial performance.

Ask your AI about PTC Therapeutics's business segments — income tax expense benefit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude